MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Imperva Company Profile (NASDAQ:IMPV)

Consensus Ratings for Imperva (NASDAQ:IMPV) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 20 Buy Rating(s)
Consensus Rating:Buy (Score: 2.79)
Consensus Price Target: $63.71 (80.24% upside)

Analysts' Ratings History for Imperva (NASDAQ:IMPV)
Show:
DateFirmActionRatingPrice TargetActions
5/22/2016Pacific CrestReiterated RatingBuy$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016OppenheimerReiterated RatingBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2016Imperial CapitalLower Price TargetOutperform$70.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016RBC CapitalReiterated RatingBuy$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Morgan StanleyReiterated RatingSell$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016WunderlichLower Price TargetBuy$62.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Piper JaffrayLower Price TargetOverweight$84.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016NomuraLower Price TargetBuy$80.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016BTIG ResearchLower Price TargetBuy$84.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Buckingham ResearchLower Price TargetBuy$80.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Deutsche BankLower Price TargetBuy$75.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Topeka Capital MarketsLower Price TargetBuy$80.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016JMP SecuritiesUpgradeMarket Perform -> Outperform$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/24/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2016Northland SecuritiesInitiated CoverageOutperform$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2016DA DavidsonUpgradeNeutral -> Buy$76.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/11/2016GuggenheimUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2015Stifel NicolausInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2015MacquarieReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2015JPMorgan Chase & Co.Reiterated RatingHold$50.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Summit ResearchInitiated CoverageBuy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015KeyBancReiterated RatingOverweight$56.00 -> $67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Citigroup Inc.Boost Price Target$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015BMO Capital MarketsLower Price TargetOutperform$56.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha